Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Absence of Entourage: Terpenoids Commonly Found inCannabis sativaDo Not Modulate the Functional Activity of Δ9-THC at Human CB1and CB2Receptors
Marina Santiago, Shivani Sachdev, Jonathon C. Arnold, et al.
Cannabis and Cannabinoid Research (2019) Vol. 4, Iss. 3, pp. 165-176
Open Access | Times Cited: 93

Showing 26-50 of 93 citing articles:

Cannabinoids: Revealing their complexity and role in central networks of fear and anxiety
Anthony Murkar, Joseph De Koninck, Zul Merali
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 30-46
Closed Access | Times Cited: 32
Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
Dan Jin, Philippe Henry, Jacqueline J. Shan, et al.
Frontiers in Plant Science (2021) Vol. 12
Open Access | Times Cited: 32
Anti-Inflammatory and Analgesic Properties of the Cannabis Terpene Myrcene in Rat Adjuvant Monoarthritis
Jason J. McDougall, Meagan McKenna
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7891-7891
Open Access | Times Cited: 22
Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation
Noa Raz, Aharon M. Eyal, Dana Berneman Zeitouni, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115548-115548
Open Access | Times Cited: 11
β-Caryophyllene Inhibits Monoacylglycerol Lipase Activity and Increases 2-Arachidonoyl Glycerol Levels In Vivo: A New Mechanism of Endocannabinoid-Mediated Analgesia?
Jost Klawitter, Wiebke Weissenborn, Iuliia Gvon, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 2, pp. 75-83
Open Access | Times Cited: 3
Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases
Paweł Śledziński, Agnieszka Nowak, Joanna Zeyland
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 263-263
Open Access | Times Cited: 33
Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?
Ersilia Nigro, Marialuisa Formato, Giuseppina Crescente, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2668-2668
Open Access | Times Cited: 27
Secondary Terpenes in Cannabis sativa L.: Synthesis and Synergy
Francisco T. Chacon, Wesley M. Raup‐Konsavage, Kent E. Vrana, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3142-3142
Open Access | Times Cited: 17
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases
Graziella dos Reis Rosa Franco, Scott D. Smid, Cláudio Viegas
Current Neuropharmacology (2020) Vol. 19, Iss. 4, pp. 449-464
Open Access | Times Cited: 27
Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds
Brittney R. Lins, Chidozie C. Anyaegbu, Sarah C. Hellewell, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Understanding feeling “high” and its role in medical cannabis patient outcomes
Sarah S. Stith, Xiaoxue Li, Franco Brockelman, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Cannabinoid treatments in epilepsy and seizure disorders
Orrin Devinsky, Nicholas A. Jones, Mark O. Cunningham, et al.
Physiological Reviews (2023) Vol. 104, Iss. 2, pp. 591-649
Closed Access | Times Cited: 8
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Edward Chesney, Philip McGuire, Tom P. Freeman, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 26
Essential Oils from Monarda fistulosa: Chemical Composition and Activation of Transient Receptor Potential A1 (TRPA1) Channels
Monica Ghosh, Igor A. Schepetkin, Gülmira Özek, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 4873-4873
Open Access | Times Cited: 25
Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder
Ewa Galaj, Guo‐Hua Bi, Allamar Moore, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 4, pp. 860-870
Open Access | Times Cited: 24
Cannabis sativa: an overview
Gary Richter, Trina Hazzah, Joshua A. Hartsel, et al.
Elsevier eBooks (2021), pp. 603-624
Open Access | Times Cited: 21
Cannabis and Inflammation in HIV: A Review of Human and Animal Studies
Ronald J. Ellis, Natalie Wilson, Scott N. Peterson
Viruses (2021) Vol. 13, Iss. 8, pp. 1521-1521
Open Access | Times Cited: 21
CB1 allosteric modulators and their therapeutic potential in CNS disorders
Catharine A. Mielnik, Vincent Lam, Ruth A. Ross
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110163-110163
Closed Access | Times Cited: 21
Barriers to the wider adoption of medicinalCannabis
S P H Alexander
British Journal of Pain (2020) Vol. 14, Iss. 2, pp. 122-132
Open Access | Times Cited: 20
β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms
Xianghu He, Ewa Galaj, Guo‐Hua Bi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 17
Cannabinoid type-2 receptors modulate terpene induced anxiety-reduction in zebrafish
Andréa Johnson, Ryan Verbitsky, James B. Hudson, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115760-115760
Open Access | Times Cited: 6
A High-Throughput Method for the Comprehensive Analysis of Terpenes and Terpenoids in Medicinal Cannabis Biomass
Christian Krill, Simone Rochfort, Germán Spangenberg
Metabolites (2020) Vol. 10, Iss. 7, pp. 276-276
Open Access | Times Cited: 18
The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis
Samuel Hammond, Simon Erridge, Nagina Mangal, et al.
Cannabis and Cannabinoid Research (2021) Vol. 6, Iss. 6, pp. 474-487
Open Access | Times Cited: 15
Evaluating Cannabis sativa L.’s neuroprotection potential: From bench to bedside
John Staton Laws, Scott D. Smid
Phytomedicine (2022) Vol. 107, pp. 154485-154485
Closed Access | Times Cited: 11
Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
Ayat Zagzoog, Ashley Cabecinha, Hanan Abramovici, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10

Scroll to top